Article Information
vol. 4 no. 10
Published By:
Online ISSN:
History:
- Received for publication February 15, 2018
- Accepted for publication September 12, 2018
Copyright & Usage:
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
Author Information
- C. Ämmälä1,*,
- W. J. Drury III1,
- L. Knerr1,
- I. Ahlstedt1,
- P. Stillemark-Billton1,
- C. Wennberg-Huldt1,
- E.-M. Andersson1,
- E. Valeur1,
- R. Jansson-Löfmark1,
- D. Janzén1,
- L. Sundström2,
- J. Meuller2,
- J. Claesson2,
- P. Andersson3,
- C. Johansson3,
- R. G. Lee4,
- T. P. Prakash4,
- P. P. Seth4,*,
- B. P. Monia4 and
- S. Andersson1
- 1Cardiovascular Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
- 2Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
- 3Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
- 4Ionis Pharmaceuticals, 2855 Gazelle Court, Carlsbad, CA 92010, USA.
- ↵*Corresponding author. Email: carina.ammala{at}astrazeneca.com (C.Ä.); pseth{at}ionisph.com (P.P.S.)
